Oct 14, 2021
ARJUNA Therapeutics announces the appointment of Mr Jo Williamson as Chief Patient Representative, and advisor to the Scientific Advisory Board (SAB).
Apr 08, 2021
ARJUNA Therapeutics, the European biotech start-up, announces the appointment of Dr Robert Barnes to the Board of Directors.
Mar 24, 2021
London, Santiago de Compostela ARJUNA Therapeutics announced today that data for Arjuna's preclinical Ag5 program will be presented at the American Association of Cancer Research (AACR) 2021 Annual Meeting.
May 11, 2020
ARJUNA Therapeutics announces the appointment of Martin Treder, PhD as Chief Scientific Officer. He will lead the development of ARJUNA's lead assets into clinical development and advance the broad pipeline of TMC compounds. Dr.
Apr 23, 2020
The Center for Advancing Innovation (CAI) announces that ARJUNA Therapeutics is one of the winners of the Brain Race, an open innovation contest to advance high-impact inventions and solutions to defeat brain tumors.
Sep 16, 2019
Santiago de Compostela, Spain and St Anselmo, California, USA